Saccharomyces boulardiiCNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea

Saccharomyces boulardiiCNCM I-745 in different clinical conditions

(2014) Ener Cagri Dinleyici et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Use of Probiotics for Management of Acute Gastroenteritis

(2014) Hania Szajewska et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe

(2014) Alfredo Guarino et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

(2014) Colin Hill et al.   Nature Reviews Gastroenterology & Hepatology

Global burden of childhood pneumonia and diarrhoea

(2013) Christa L Fischer Walker et al.   LANCET

Effectiveness and safety ofSaccharomyces boulardiifor acute infectious diarrhea

(2012) Ener Cagri Dinleyici et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

World Gastroenterology Organisation Global Guidelines

(2012) Francisco Guarner et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Probiotic, zinc and lactose-free formula in children with rotavirus diarrhea: Are they effective?

(2011) Nazan Dalgic et al.   PEDIATRICS INTERNATIONAL

Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

(2011) Theodoros Kelesidis et al.   Therapeutic Advances in Gastroenterology

Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients

(2010) Lynne V McFarland   WORLD JOURNAL OF GASTROENTEROLOGY

Twenty-Five Years of Research on Saccharomyces boulardii Trophic Effects: Updates and Perspectives

(2008) Jean-Paul Buts   DIGESTIVE DISEASES AND SCIENCES